BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE NDC 69238-1993

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1993Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1993Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1993-1	69238199301	100 CAPSULE in 1 BOTTLE (69238-1993-1)Marketed from Apr 1, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE
Generic name (nonproprietary): butalbital, aspirin, caffeine and codeine phosphate
Active ingredients: Butalbital — 50 mg/1Aspirin — 325 mg/1Caffeine — 40 mg/1Codeine phosphate — 30 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals of New York, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 074951
Marketing start: Apr 1, 2019
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Non-Steroidal (Chemical structure)Barbiturates (Chemical structure)Central Nervous System Stimulation (Physiologic effect)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)Full Opioid Agonists (Mechanism)Xanthines (Chemical structure)
Identifiers: Product ID 69238-1993_f3869a7a-b5f3-4279-b07b-ff01a8c2a286SPL ID f3869a7a-b5f3-4279-b07b-ff01a8c2a286SPL set ID 828e30fa-7bb1-486b-80ee-806fce45e4e4RxCUI 994237UNII KHS0AZ4JVK, R16CO5Y76E, 3G6A5W338E, GSL05Y1MN6UPC 0369238199314
Pharmacologic class: Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Opioid Agonist; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238199301 followed by a unit qualifier and the quantity

Package 69238-1993-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is indicated for the management of the symptom complex of tension (or muscle contraction) headache, when non-opioid analgesic and alternative treatments are inadequate. BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is a combination of butalbital, a barbiturate, aspirin, a nonsteroidal anti-inflammatory drug, caffeine, a methylxanthine, and codeine phosphate, an opioid agonist, and is indicated for the management of the symptom complex of tension (or muscle contraction) headache, when other non-opioid analgesics and alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)